Tiziana Life Sciences
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-03-31 |
|---|---|---|
Gross Profit | -158 | -11,946 |
EBITDA | -12,229 | -12,653 |
EBIT | -12,387 | -12,799 |
Net Income | -12,387 | -12,799 |
Free Cash Flow | -7,416 | -6,039 |
Cash | 3,178 | 4,010 |
Basic Shares | 127,873 | 118,282 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -234 | -14,586 | ||
EBITDA | -18,179 | -16,616 | -17,136 | -15,339 |
EBIT | -18,413 | -16,740 | -17,232 | -15,390 |
Net Income | -18,431 | -11,863 | -17,691 | -15,397 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -12,868 | -1,234 | -12,422 | -15,990 |
Cash | 4,010 | 3,724 | 1,183 | 18,122 |
Basic Shares | 118,282 | 106,672 | 102,471 | 101,526 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.05 |
2025-03-31 | -$0.07 |
2024-09-30 | -$0.05 |
2022-09-30 | -$0.06 |